The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo
Abstract
Inhibitory molecules derived from CNS myelin and glial scar tissue are major causes for insufficient functional regeneration in the mammalian CNS. A multitude of these molecules signal through the Rho/Rho kinase (ROCK) pathway. We evaluated three inhibitors of ROCK, Y- 27632, Fasudil (HA-1077), and Dimethylfasudil (H-1152), in models of neurite outgrowth in vitro. We show, that all three ROCK inhibitors partially restore neurite outgrowth of Ntera-2 neurons on the inhibitory chondroitin sulphate proteoglycan substrate. In the rat optic nerve crush model Y-27632 dose-dependently increased regeneration of retinal ganglion cell axons in vivo. Application of Dimethylfasudil showed a trend towards increased axonal regeneration in an intermediate concentration. We demonstrate that inhibition of ROCK can be an effective therapeutic approach to increase regeneration of CNS neurons. The selection of a suitable inhibitor with a broad therapeutic window, however, is crucial in order to minimize unwanted side effects and to avoid deleterious effects on nerve fiber growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It integrates molecular signals to organize sophisticated and coordinated variations in gene expression and actin cytoskeleton, crucial processes for the neurite outgrowth and synaptic connectivity [53,54].”
From Brain Cholesterol Biosynthetic Pathway Is Altered in a Preclinical Model of Fragile X Syndrome (2022) · cites this paper as [53]
Citations
Cites
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 4,366
Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization
Yang, N., Higuchi, O., Ohashi, K., Nagata, K., Wada, A., Kangawa, K., Nishida, E., & Mizuno, K. (1998) · Nature · doi:10.1038/31735 · Cited by 1,296
Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., & Narumiya, S. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26508-1 · Cited by 940
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J. K., Levesque, M., Allaire, N., Perrin, S., Sands, B., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1188 · Cited by 827
Rho Signaling Pathway Targeted to Promote Spinal Cord Repair
Dergham, P., Ellezam, B., Essagian, C., Avedissian, H., Lubell, W. D., & McKerracher, L. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06570.2002 · Cited by 725
Rho Kinase Inhibition Enhances Axonal Regeneration in the Injured CNS
Fournier, A. E., Takizawa, B. T., & Strittmatter, S. M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01416.2003 · Cited by 644
cAMP-induced switching in turning direction of nerve growth cones
Song, H., Ming, G., & Poo, M.-M. (1997) · Nature · doi:10.1038/40864 · Cited by 620
Rho kinase, a promising drug target for neurological disorders
Mueller, B. K., Mack, H., & Teusch, N. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1719 · Cited by 609
Self-citationLang, P., Gesbert, F., Delespine‐Carmagnat, M., Stancou, R., Pouchelet, M., & Bertoglio, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00383.x · Cited by 558
Shamah, S. M., Lin, M. Z., Goldberg, J. L., Estrach, S., Şahin, M., Hu, L. S., Bazalakova, M. H., Neve, R. L., Corfas, G., Debant, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00314-2 · Cited by 544
Research works printed but not linked: 1
- 10.1042/bj3510095 · DOI
Cited by
Sorted by citations
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
The retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,458
Axon growth inhibition by RhoA/ROCK in the central nervous system
Fujita, Y., & Yamashita, T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00338 · Cited by 279
Mechanisms of acute axonal degeneration in the optic nerve in vivo
Knöferle, J., Koch, J. C., Ostendorf, T., Michel, U., Planchamp, V., Vutova, P., Tönges, L., Stadelmann, C., Brück, W., Bähr, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909794107 · Cited by 310
Self-citationROCK inhibition in models of neurodegeneration and its potential for clinical translation
Koch, J. C., Tatenhorst, L., Roser, A.-E., Saal, K.-A., Tönges, L., & Lingor, P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.008 · Cited by 239
Self-citationLingor, P., Tönges, L., Pieper, N., Bermel, C., Barski, E., Planchamp, V., & Bähr, M. (2007) · Brain · doi:10.1093/brain/awm284 · Cited by 246
Self-citationROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
Koch, J. C., Tönges, L., Barski, E., Michel, U., Bähr, M., & Lingor, P. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.191 · Cited by 197
Self-citationEnhancing remyelination in disease--can we wrap it up?
Kotter, M., Stadelmann, C., & Hartung, H. ‐. (2011) · Brain · doi:10.1093/brain/awr014 · Cited by 182
Tonges, L., Frank, T., Tatenhorst, L., Saal, K. A., Koch, J. C., Szego, E. M., Bahr, M., Weishaupt, J. H., & Lingor, P. (2012) · Brain · doi:10.1093/brain/aws254 · Cited by 176
Self-citationKwok, J. C. F., Afshari, F. T., García‐Alías, G., & Fawcett, J. W. (2008) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2008-00439 · Cited by 170
Promoting optic nerve regeneration
Fischer, D., & Leibinger, M. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.06.005 · Cited by 152
Tönges, L., Günther, R., Suhr, M., Jansen, J., Balck, A., Saal, K., Barski, E., Nientied, T., Götz, A. A., Koch, J., et al. (2014) · Glia · doi:10.1002/glia.22601 · Cited by 121
Self-citationThe therapeutic effects of Rho-ROCK inhibitors on CNS disorders
Kubo, T. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s2907 · Cited by 122
Kwon, B. K., & Tetzlaff, W. (2001) · Spine · doi:10.1097/00007632-200112151-00003 · Cited by 116
Statins and the Brain: More than Lipid Lowering Agents?
Fracassi, A., Marangoni, M., Rosso, P., Pallottini, V., Fioramonti, M., Siteni, S., & Segatto, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170703101816 · Cited by 116
Chondroitin sulphate proteoglycans: Key modulators of spinal cord and brain plasticity
Bartus, K., James, N. D., Bosch, K. D., & Bradbury, E. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.008 · Cited by 121
ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration
Tönges, L. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00039 · Cited by 116
Loh, S. H. Y., Francescut, L., Lingor, P., Bähr, M., & Nicotera, P. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402258 · Cited by 108
Self-citationMesentier-Louro, L. A., Zaverucha-do-Valle, C., da Silva‐Junior, A. J., Nascimento‐dos‐Santos, G., Gubert, F., Ana, B. P. D. F., Torres, A. L. M., Paredes, B. D., Teixeira, C. D. S., Tovar-Moll, F. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110722 · Cited by 109
Peripheral delivery of a ROCK inhibitor improves learning and working memory.
Huentelman, M. J., Stephan, D. A., Talboom, J. S., Corneveaux, J. J., Reiman, D., Gerber, J. D., Barnes, C. A., Alexander, G. E., Reiman, E. M., & Bimonte‐Nelson, H. A. (2009) · Behavioral Neuroscience · doi:10.1037/a0014260 · Cited by 107
Young, W. (2014) · Cell Transplantation · doi:10.3727/096368914x678427 · Cited by 106
Monnier, P. P., D’Onofrio, P. M., Magharious, M. M., Hollander, A. C., Tassew, N. G., Szydłowska, K., Tymianski, M., & Koeberle, P. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0148-11.2011 · Cited by 99
Boulanger, J. J., & Messier, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.063 · Cited by 93
Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC
Filous, A. R., Miller, J. H., Coulson‐Thomas, Y. M., Horn, K. P., Alilain, W. J., & Silver, J. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20820 · Cited by 93
Watzlawick, R., Sena, E. S., Dirnagl, U., Brommer, B., Kopp, M. A., Macleod, M. R., Howells, D. W., & Schwab, J. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4684 · Cited by 101
Multi-compartment neuron–glia co-culture platform for localized CNS axon–glia interaction study
Park, J., Koito, H., Li, J., & Han, A. (2012) · Lab on a Chip · doi:10.1039/c2lc40303j · Cited by 86
Lingor, P., Weber, M., Camu, W., Friede, T., Hilgers, R., Leha, A., Neuwirth, C., Günther, R., Benatar, M. G., Kuźma‐Kozakiewicz, M., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00293 · Cited by 85
Self-citationRho/Rho-associated kinase pathway in glaucoma
WANG, J., Liu, X., & Zhong, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2100 · Cited by 88
Tagami, Y., Kurimoto, T., Miyoshi, T., Morimoto, T., Sawai, H., & Mimura, O. (2009) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-009-0657-8 · Cited by 81
Ma, T. C., Campana, A., Lange, P. S., Lee, H., Banerjee, K., Bryson, J. B., Mahishi, L., Alam, S., Giger, R. J., Barnes, S., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5266-09.2010 · Cited by 79
Ding, J., Li, Q., Wang, X., Sun, C., Lu, C., & Xiao, B. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06876.x · Cited by 79
BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activity
Planchamp, V., Bermel, C., Tönges, L., Ostendorf, T., Kügler, S., Reed, J. C., Kermer, P., Bähr, M., & Lingor, P. (2008) · Brain · doi:10.1093/brain/awn196 · Cited by 77
Self-citationde Velde, S. V., Groef, L. D., Stalmans, I., Moons, L., & Hove, I. V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.06.002 · Cited by 76
Liu, J., Gao, H., & Wang, X. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.170325 · Cited by 75
Central Nervous System Regeneration Inhibitors and their Intracellular Substrates
Nash, M., Pribiag, H., Fournier, A. E., & Jacobson, C. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8083-y · Cited by 75
Tan, H., Zhong, Y.-S., Cheng, Y., & Shen, X. (2011) · PubMed Central · doi:10.3980/j.issn.2222-3959.2011.06.16 · Cited by 72
Saal, K., Koch, J. C., Tatenhorst, L., Szegő, É. M., Ribas, V. T., Michel, U., Bähr, M., Tönges, L., & Lingor, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.013 · Cited by 72
Self-citationProspects for mTOR-mediated functional repair after central nervous system trauma
Berry, M., Ahmed, Z., Morgan-Warren, P. J., Fulton, D. J., & Logan, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.002 · Cited by 67
Howell, M. D., & Gottschall, P. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.034 · Cited by 70
Four Steps to Optic Nerve Regeneration
Moore, D. L., & Goldberg, J. L. (2010) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e3181e755af · Cited by 67
Exploring Optic Nerve Axon Regeneration
Li, H., Sun, Z.-L., Yang, X., Zhu, L., & Feng, D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161227150250 · Cited by 66
Calcium-sensing Receptor Modulates Cell Adhesion and Migration via Integrins
Tharmalingam, S., Daulat, A. M., Antflick, J. E., Ahmed, S. M., Nemeth, E. F., Angers, S., Conigrave, A. D., & Hampson, D. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.265454 · Cited by 66
Hannan, J. L., Albersen, M., Kutlu, Ö., Gratzke, C., Stief, C. G., Burnett, A. L. “., Lysiak, J. J., Hedlund, P., & Bivalacqua, T. J. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.09.104 · Cited by 66
Shaw, P. X., Sang, A., Wang, Y., Ho, D., Douglas, C. R., Dia, L., & Goldberg, J. L. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.07.006 · Cited by 65
Xiao, B., Ma, C., Wang, Q., Song, L.-J., Ding, Z., Chai, Z., & Yu, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335827 · Cited by 62
A microchip for quantitative analysis of CNS axon growth under localized biomolecular treatments
Park, J., Kim, S.-J., Park, S. I., Choe, Y., Li, J., & Han, A. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.09.018 · Cited by 67
Exploiting mTOR Signaling: A Novel Translatable Treatment Strategy for Traumatic Optic Neuropathy?
Morgan-Warren, P. J., Berry, M., Ahmed, Z., Scott, R. A. H., & Logan, A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12803 · Cited by 63
Wong, L., Tann, J. Y., Ibáñez, C. F., & Sajikumar, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2876-18.2019 · Cited by 63
Gu, H., Yu, S. P., Gutekunst, C., Gross, R. E., & Wei, L. (2013) · Europe PMC (PubMed Central) · Cited by 62
Gopalakrishnan, S. M., Teusch, N., Imhof, C., Bakker, M. H. M., Schurdak, M., Burns, D. J., & Warrior, U. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21671 · Cited by 62
Self-citationTwo PTP receptors mediate CSPG inhibition by convergent and divergent signaling pathways in neurons
Ohtake, Y., Wong, D., Abdul-Muneer, P. M., Selzer, M. E., & Li, S. (2016) · Scientific Reports · doi:10.1038/srep37152 · Cited by 59
Ding, J., Yu, J., Li, Q., Wang, X., Lü, C., & Xiao, B. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.05.002 · Cited by 60
Abeysinghe, H. C. S., Phillips, E., Chin-Cheng, H., Beart, P. M., & Roulston, C. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030288 · Cited by 62
Usher, L., Johnstone, A. L., Ertürk, A., Hu, Y. J., Strikis, D., Wanner, I. B., Moorman, S., Lee, J.-W., Min, J., Ha, H., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0302-10.2010 · Cited by 58
Ahmed, Z., Berry, M., & Logan, A. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.06.005 · Cited by 58
Roloff, F., Scheiblich, H., Dewitz, C., Dempewolf, S., Stern, M. K., & Bicker, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118536 · Cited by 58
Axon plasticity in the mammalian central nervous system after injury
Chen, M., & Zheng, B. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.008 · Cited by 63
Tatenhorst, L., Tönges, L., Saal, K., Koch, J. C., Szegő, É. M., Bähr, M., & Lingor, P. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000095 · Cited by 56
Self-citationWong, L., Chong, Y. S., Lin, W., Kisiswa, L., Sim, E. W., Ibáñez, C. F., & Sajikumar, S. (2021) · Aging Cell · doi:10.1111/acel.13305 · Cited by 58
In vitro models of axon regeneration
Al‐Ali, H., Beckerman, S. R., Bixby, J. L., & Lemmon, V. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.01.020 · Cited by 60
Ding, J., Li, Q., Yu, J., Wang, X., Sun, C., Lü, C., & Xiao, B. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.11.001 · Cited by 52
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson’s Disease
Labandeira-Garcia, J. L., Rodríguez-Perez, A. I., Villar-Cheda, B., Borrajo, A., Dominguez-Meijide, A., & Guerra, M. J. (2015) · The Neuroscientist · doi:10.1177/1073858414554954 · Cited by 54
The Rho Kinase Pathway Regulates Mouse Adult Neural Precursor Cell Migration
Leong, S. Y., Faux, C. H., Turbić, A., Dixon, K. J., & Turnley, A. M. (2010) · Stem Cells · doi:10.1002/stem.577 · Cited by 49
Segatto, M., Manduca, A., Lecis, C., Rosso, P., Jozwiak, A., Swiezewska, E., Moreno, S., Trezza, V., & Pallottini, V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.284 · Cited by 51
Lau, C. L., Perreau, V. M., Chen, M. J., Cate, H. S., Merlo, D., Cheung, N. S., O'Shea, R. D., & Beart, P. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22838 · Cited by 49
Glaucoma and optic nerve repair
Diekmann, H., & Fischer, D. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1596-8 · Cited by 50
Kilinc, D., Blasiak, A., O’Mahony, J. J., & Lee, G. U. (2014) · Scientific Reports · doi:10.1038/srep07128 · Cited by 46
Lamas, N. J., Johnson-Kerner, B., Roybon, L., Kim, Y. A., Garcia-Diaz, A., Wichterle, H., & Henderson, C. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110324 · Cited by 50
Rho kinase inhibitors: a patent review (2012 – 2013)
Feng, Y., & LoGrasso, P. V. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.863279 · Cited by 46
Tseng, Y., Lin, W., Chang, W., & Lo, Y. (2018) · Phytotherapy Research · doi:10.1002/ptr.6259 · Cited by 46
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design.
Hobson, A. D., Judge, R. A., Aguirre, A. L., Brown, B. S., Cui, Y., Ding, P., Dominguez, E., DiGiammarino, E., Egan, D. A., Freiberg, G. M., et al. (2018) · PubMed · doi:10.1021/acs.jmedchem.8b01098 · Cited by 15
Self-citationQuantitative iTRAQ Analysis of Retinal Ganglion Cell Degeneration after Optic Nerve Crush
Magharious, M. M., D’Onofrio, P. M., Hollander, A. C., Zhu, P., Chen, J., & Koeberle, P. D. (2011) · Journal of Proteome Research · doi:10.1021/pr2004055 · Cited by 42
ROCK-2-selective targeting and its therapeutic outcomes
Sharma, P., & Roy, K. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.017 · Cited by 40
Chemical Interrogation of the Neuronal Kinome Using a Primary Cell-Based Screening Assay
Al‐Ali, H., Schürer, S. C., Lemmon, V., & Bixby, J. L. (2013) · ACS Chemical Biology · doi:10.1021/cb300584e · Cited by 39
Ichikawa, M., Yoshida, J., Saito, K., Sagawa, H., Tokita, Y., & Watanabe, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.063 · Cited by 39
Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration
Brochier, C., Jones, J. I., Willis, D. E., & Langley, B. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509754112 · Cited by 39
Targeting cerebrovascular Rho-kinase in stroke
Shin, H. K., Salomone, S., & Ayata, C. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802539244 · Cited by 38
Siebert, J. R., Eade, A. M., & Osterhout, D. J. (2015) · BioMed Research International · doi:10.1155/2015/752572 · Cited by 40
Koch, J. C., Solis, G. P., Bodrikov, V., Michel, U., Haralampieva, D., Shypitsyna, A., Tönges, L., Bähr, M., Lingor, P., & Stuermer, C. A. O. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.007 · Cited by 37
Self-citationAMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy
Hollanders, K., Hove, I. V., Sergeys, J., Bergen, T. V., Lefevere, E., Kindt, N., Castermans, K., Vandewalle, E., van Pelt, J. F., Moons, L., et al. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1183030 · Cited by 38
Regulation of adult neural precursor cell migration
Leong, S. Y., & Turnley, A. M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.024 · Cited by 37
Spinal cord injury I: A synopsis of the basic science.
Webb, A. A., Ngan, S., & Fowler, J. D. (2010) · PubMed Central · Cited by 37
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1G93A mice
nther, R. G. ⁄., Saal, K., Suhr, M., Scheer, D., Koch, J. C., Bähr, M., Lingor, P., & Tönges, L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00304 · Cited by 36
Self-citationRho Signaling and Axon Regeneration
McKerracher, L. J., Ferraro, G. B., & Fournier, A. E. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-398309-1.00007-x · Cited by 35
Sanjurjo-Soriano, C., & Kalatzis, V. (2018) · Neural Plasticity · doi:10.1155/2018/5056279 · Cited by 38
Wu, D., Yang, P., Zhang, X., Luo, J., Haque, M. E., Yeh, J., Richardson, P. M., Zhang, Y., & Bo, X. (2009) · Molecular Therapy · doi:10.1038/mt.2009.168 · Cited by 35
Scalzone, A., Bonifacio, M. A., Cometa, S., Cucinotta, F., Giglio, E. D., Ferreira, A. M., & Gentile, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00712 · Cited by 35
ROCK inhibitors for the treatment of ocular diseases
Nourinia, R., Nakao, S., Zandi, S., Safi, S., Hafezi‐Moghadam, A., & Ahmadieh, H. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-310378 · Cited by 35
Huang, L., Li, Q., Li, H., He, Z., Cheng, Z., Chen, J., & Guo, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.053 · Cited by 33
Bermel, C., Tönges, L., Planchamp, V., Gillardon, F., Weishaupt, J. H., Dietz, G. P. H., Bähr, M., & Lingor, P. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.09.005 · Cited by 32
Self-citationROCK as a Therapeutic Target of Diabetic Retinopathy
Arita, R., Hata, Y., & Ishibashi, T. (2010) · Journal of Ophthalmology · doi:10.1155/2010/175163 · Cited by 32
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
Xin, Y.-L., Yu, J., Yang, X., Liu, C., Li, Y., Feng, L., Chai, Z., Yang, W., Wang, Q., Jiang, W., et al. (2015) · Bioscience Reports · doi:10.1042/bsr20150032 · Cited by 31
Deng, Y.-P., Sun, Y., Hu, L., Li, Z., Xu, Q., Pei, Y.-L., Huang, Z., Yang, Z., & Chen, C. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.026 · Cited by 31
Zhang, X., Cheng, L., Gao, H., Nabeka, H., Shimokawa, T., Wakisaka, H., Matsuda, S., & Kobayashi, N. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0006-z · Cited by 30
Adult hippocampal neurogenesis, Rho kinase inhibition and enhancement of neuronal survival
Christie, K. J., Turbić, A., & Turnley, A. M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.019 · Cited by 30
Lai, A. Y., & McLaurin, J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14130 · Cited by 31
Construction and reconstruction of brain circuits: normal and pathological axon guidance
Roig‐Puiggros, S., Vigouroux, R. J., Beckman, D., Bocai, N. I., Chiou, B., Davimes, J. G., Gómez, G., Grassi, S., Hoque, A., Karikari, T. K., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14900 · Cited by 29
Chen, S., Luo, M., Zhao, Y., Zhang, Y., He, M., Cai, W., & Liu, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430118 · Cited by 27
Lǐ, Y., Yu, J., Liu, C., Zhang, H., Zhang, H., Yang, W., Li, J., Feng, Q., Feng, L., Zhang, G., et al. (2014) · Immunology · doi:10.1111/imm.12303 · Cited by 26
The Histone Methyltransferase G9a Controls Axon Growth by Targeting the RhoA Signaling Pathway
Wilson, C., Giono, L. E., Rozés‐Salvador, V., Fiszbein, A., Kornblihtt, A. R., & Cáceres, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107639 · Cited by 26
Metadata
- Authors
- Lingor, P., Teusch, N., Schwarz, K., Mueller, R., Mack, H., Bähr, M., & Mueller, B. K.
- Affiliations
- University of Göttingen (DE)
- Abbott (Germany) (DE)
- Corresponding author
- Bähr, Mathias
- Mueller, Bernhard K.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-06-09
- Volume
- 103
- Issue
- 1
- Pages
- 181-189
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2011497398
- Cited by
- 214
- References
- 37
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 13 · 2021: 5 · 2020: 14 · 2019: 9 · 2018: 15 · 2017: 10 · 2016: 17 · 2015: 15 · 2014: 23 · 2013: 17 · 2012: 14
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- Rho kinase inhibition, ROCK inhibitor, neurite outgrowth, chondroitin sulfate proteoglycans, axon regeneration, optic nerve crush, retinal ganglion cells, Y-27632, fasudil, glial scar, central nervous system regeneration
- MeSH terms
- Amides, Animals, Axons, Cell Line, Dose-Response Relationship, Drug, Enzyme Inhibitors, Female, Humans, Nerve Crush, Nerve Regeneration, Neurons, Optic Nerve, Chondroitin Sulfate Proteoglycans, Pyridines, Neurites, Rats, Wistar, Protein Serine-Threonine Kinases, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Optic Nerve Injuries, Intracellular Signaling Peptides and Proteins, Rats, rho-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review